Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Current Deferred Revenue (2016 - 2025)

Mesa Laboratories' Current Deferred Revenue history spans 13 years, with the latest figure at $14.6 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 1.03% to $14.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.6 million, a 1.03% decrease, with the full-year FY2025 number at $14.7 million, down 4.96% from a year prior.
  • Current Deferred Revenue hit $14.6 million in Q4 2025 for Mesa Laboratories, up from $14.3 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for MLAB hit a ceiling of $16.3 million in Q3 2022 and a floor of $8.8 million in Q1 2021.
  • Historically, Current Deferred Revenue has averaged $14.0 million across 5 years, with a median of $14.6 million in 2022.
  • Biggest five-year swings in Current Deferred Revenue: surged 80.59% in 2021 and later dropped 10.04% in 2023.
  • Tracing MLAB's Current Deferred Revenue over 5 years: stood at $13.8 million in 2021, then grew by 5.62% to $14.6 million in 2022, then fell by 1.56% to $14.4 million in 2023, then increased by 2.46% to $14.7 million in 2024, then fell by 1.03% to $14.6 million in 2025.
  • Business Quant data shows Current Deferred Revenue for MLAB at $14.6 million in Q4 2025, $14.3 million in Q3 2025, and $15.1 million in Q2 2025.